FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2805241497> ?p ?o ?g. }

• W2805241497 abstract "For thousands of years, natural products have played important roles throughout the world in preventing and treating human diseases. Black cumin (Nigella sativa L.) and its bioactive constituents, thymoquinone (TQ), have been used for various health benefits such as antidiabetic, antitumor, antihypertensive, antioxidative and antibacterial agents. Type 2 diabetes mellitus (T2DM) which accounts for over 90 % of diabetes cases is currently a major chronic disease affecting about 6 % of the global population. Therefore, discovering new therapies is vital for management of T2DM. Although TQ and thymoquinone rich fraction (TQRF) are known to be powerful antioxidants and have hypoglycemic properties, their administration in vivo remains problematic partly due to their low bioavailability. Lipid nanoemulsions from some medicinal plant oils such as TQRF or from hydrophobic bioactives such as TQ are attractive candidates for improving solubility and bioavailability of the oils and their bioactives. Therefore, the aim of the present study was to develop, characterize, and investigate antidiabetic properties of TQRF nanoemulsion (TQRFNE) and TQ nanoemulsion (TQNE). Conventional emulsions from TQRF (TQRFCE) and from TQ (TQCE) were also prepared for comparison. TQRF extracted from N. sativa using supercritical fluid extraction (SFE) contained 4.45 % TQ and was used to develop TQRFNE and TQRFCE. To develop TQNE and TQCE, Triolein (TR) was used as a carrier of commercially acquired TQ based on the concentration of TQ in TQRF. Conventional emulsions were prepared first by mixing 5 % lipid phase (TQRF or TR which contains calculated amount of TQ) with 95 % aqueous phase (2 % Tween-80, and 93 % distilled water) at room temperature using Ultra-Turrax mixer (13000 rpm / 3 min). Nanoemulsions were produced by passing the conventional emulsions through high pressure Homogenizer (800 bars and five homogenization cycles). In the characterization study, the changes in particle size, zeta potential,polydispersity index, refractive index, and chemical stability (loss of TQ during storage) of all emulsions were investigated over a period of 6 months at three different storage temperatures (4, 25, and 40 ˚C). At the end of characterization period, all nanoemulsions displayed good physical and chemical stability; there was no phase separation or any sign of instability of all nanoemulsion samples. In the antioxidant study, all emulsion samples were tested for antioxidant activity against 1,1-diphenyl-2-picrylhydrazyl (DPPH•), 2,2-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS•+), and β-carotene bleaching (BCB) assays using UV- visible spectrophotometer, and hydroxyl radical scavenging activity by electron spin resonance (ESR) spectrometer. Antioxidant activities of all nanoemulsions were slightly lower compared to conventional emulsions. In addition, acute toxicity of TQRFNE, and TQNE was studied using Sprague–Dawley rats. All the parameters measured were unaffected as compared to the negative control group (administered with distilled water). Further study was done to investigate the antidiabetic properties of the emulsions using T2DM animal model. Rats treated with TQRFNE and TQNE (10 ml/kg bw) exhibited a significant (P < 0.05) reduction in plasma total cholesterol levels (43 and 58 %), triglyceride (45 and 59 %), and fasting plasma glucose (42.1 and 54.9 %), respectively, compared to diabetic rats (DC group). However, TQRFCE and TQCE (10 ml/kg bw) also exhibited a significant (P < 0.05) reduction in plasma total cholesterol levels (56 and 69 %), triglyceride (57 and 67 %), and fasting plasma glucose (58 and 54.2 %), respectively, compared to DC group. For the liver and kidney function tests, the concentration of Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Aspartate aminotransferase (AST), Urea (URE), and Creatinine (CREA) were also measured to test any toxic effect on all tested groups. All tested parameters were also significantly lower compared to DC group. For the gene expression study, genes related to glucose metabolism (FBP1), cholesterol metabolism (LDL-R) and antioxidants (SOD1) were evaluated in this study. Treatment with TQRFNE showed antihyperglycemic,hypocholesterolemic and antioxidant effects, partly through regulation of above mentioned genes. Taken together, our finding showed that TQRFNE as a novel nanocarrier has the potential to produce better metabolic outcomes in T2DM. In addition, the findings also suggest that TQRFNE may be better than metformin in management of T2DM, and that it potentially could improve the wellbeing of diabetics through better control of metabolic indices, and likely fewer side effects." @default.
• W2805241497 created "2018-06-13" @default.
• W2805241497 creator A5051920108 @default.
• W2805241497 date "2013-08-01" @default.
• W2805241497 modified "2023-09-23" @default.
• W2805241497 title "Development, characterization and anti-diabetic properties of thymoquinone rich fraction nanoemulsion obtained from black cumin" @default.
• W2805241497 hasPublicationYear "2013" @default.
• W2805241497 type Work @default.
• W2805241497 sameAs 2805241497 @default.
• W2805241497 citedByCount "0" @default.
• W2805241497 crossrefType "dissertation" @default.
• W2805241497 hasAuthorship W2805241497A5051920108 @default.
• W2805241497 hasConcept C181389837 @default.
• W2805241497 hasConcept C185592680 @default.
• W2805241497 hasConcept C2778004101 @default.
• W2805241497 hasConcept C2779034068 @default.
• W2805241497 hasConcept C2993714443 @default.
• W2805241497 hasConcept C43617362 @default.
• W2805241497 hasConcept C55493867 @default.
• W2805241497 hasConcept C556039675 @default.
• W2805241497 hasConcept C71924100 @default.
• W2805241497 hasConcept C98274493 @default.
• W2805241497 hasConceptScore W2805241497C181389837 @default.
• W2805241497 hasConceptScore W2805241497C185592680 @default.
• W2805241497 hasConceptScore W2805241497C2778004101 @default.
• W2805241497 hasConceptScore W2805241497C2779034068 @default.
• W2805241497 hasConceptScore W2805241497C2993714443 @default.
• W2805241497 hasConceptScore W2805241497C43617362 @default.
• W2805241497 hasConceptScore W2805241497C55493867 @default.
• W2805241497 hasConceptScore W2805241497C556039675 @default.
• W2805241497 hasConceptScore W2805241497C71924100 @default.
• W2805241497 hasConceptScore W2805241497C98274493 @default.
• W2805241497 hasLocation W28052414971 @default.
• W2805241497 hasOpenAccess W2805241497 @default.
• W2805241497 hasPrimaryLocation W28052414971 @default.
• W2805241497 hasRelatedWork W1534273295 @default.
• W2805241497 hasRelatedWork W196460190 @default.
• W2805241497 hasRelatedWork W1973407593 @default.
• W2805241497 hasRelatedWork W2035582654 @default.
• W2805241497 hasRelatedWork W2059518579 @default.
• W2805241497 hasRelatedWork W2231180100 @default.
• W2805241497 hasRelatedWork W2536626900 @default.
• W2805241497 hasRelatedWork W2789488232 @default.
• W2805241497 hasRelatedWork W2923610755 @default.
• W2805241497 hasRelatedWork W2992907945 @default.
• W2805241497 hasRelatedWork W2995044704 @default.
• W2805241497 hasRelatedWork W3004116851 @default.
• W2805241497 hasRelatedWork W3088083974 @default.
• W2805241497 hasRelatedWork W3128816603 @default.
• W2805241497 hasRelatedWork W3157058864 @default.
• W2805241497 hasRelatedWork W3186085792 @default.
• W2805241497 hasRelatedWork W1947604551 @default.
• W2805241497 hasRelatedWork W2407445667 @default.
• W2805241497 hasRelatedWork W2469211459 @default.
• W2805241497 hasRelatedWork W3113286364 @default.
• W2805241497 isParatext "false" @default.
• W2805241497 isRetracted "false" @default.
• W2805241497 magId "2805241497" @default.
• W2805241497 workType "dissertation" @default.